Allogene Therapeutics, Inc.
ALLO
$1.21
-$0.01-0.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 273.12M | 280.04M | 292.48M | 291.56M | 444.63M |
| Total Receivables | 1.70M | 2.30M | 1.90M | 2.80M | 2.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.84M | 9.23M | 9.01M | 10.05M | 10.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 282.66M | 291.58M | 303.39M | 304.42M | 457.12M |
|
|
|||||
| Total Current Assets | 282.66M | 291.58M | 303.39M | 304.42M | 457.12M |
| Net Property, Plant & Equipment | 120.82M | 127.07M | 131.26M | 135.30M | 150.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.60M | 33.83M | 33.39M | 37.58M | 38.16M |
| Total Assets | 470.59M | 507.98M | 548.71M | 589.12M | 646.88M |
|
|
|||||
| Total Accounts Payable | 4.85M | 5.06M | 5.39M | 5.51M | 12.94M |
| Total Accrued Expenses | 19.07M | 17.33M | 21.55M | 19.68M | 17.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.76M | 7.63M | 7.51M | 7.39M | 7.22M |
| Total Finance Division Other Current Liabilities | -- | -- | 1.07M | -- | -- |
| Total Other Current Liabilities | -- | -- | 1.07M | -- | -- |
| Total Current Liabilities | 31.68M | 30.02M | 35.52M | 32.57M | 37.31M |
|
|
|||||
| Total Current Liabilities | 31.68M | 30.02M | 35.52M | 32.57M | 37.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 79.24M | 81.29M | 83.25M | 85.14M | 86.99M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.12M | 11.28M | 7.76M | 7.67M | 7.55M |
| Total Liabilities | 126.03M | 122.59M | 126.53M | 125.37M | 131.85M |
|
|
|||||
| Common Stock & APIC | 2.28B | 2.26B | 2.24B | 2.22B | 2.21B |
| Retained Earnings | -1.93B | -1.88B | -1.82B | -1.76B | -1.69B |
| Treasury Stock & Other | -45.00K | 43.00K | -89.00K | 157.00K | -780.00K |
| Total Common Equity | 344.56M | 385.39M | 422.18M | 463.75M | 515.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 344.56M | 385.39M | 422.18M | 463.75M | 515.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 344.56M | 385.39M | 422.18M | 463.75M | 515.04M |
|
|
|||||